David Garrick

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Venues

Cancer immunology research

Leukemia

Blood advances

EJHaem

INSERM

University of Sydney (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM

France

Chercheur :: U976, Immunologie humaine, physiopathologie et immunothérapie

Université Paris Diderot

France

Post-doctoral fellow :: Institut Universitaire d'Hématologie

Medical Research Council

United Kingdom

Researcher :: Weatherall Institute of Molecular Medicine, University of Oxford

Medical Research Council

United Kingdom

Post-doctoral fellow :: Weatherall Institute of Molecular Medicine, University of Oxford

Education History

University of Sydney

Australia

PHD :: Biochemistry

University of Sydney

Australia

BSC

Publications

Nathalie Roders, Cecilia Nakid-Cordero, Fabio Raineri, Maxime Fayon, Audrey Abecassis, Caroline Choisy, Elisabeth Nelson, Claire Maillard, David Garrick, Alexis Talbot, Jean-Paul Fermand, Bertrand Arnulf, Jean-Christophe Bories
Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple Myeloma. Cancer immunology research 12 (4) (2024)
Nathalie Roders, Cecilia Nakid-Cordero, Fabio Raineri, Maxime Fayon, Audrey Abecassis, Caroline Choisy, Elisabeth Nelson, Claire Maillard, David Garrick, Alexis Talbot, Jean-Paul Fermand, Bertrand Arnulf, Jean-Christophe Bories
Dual chimeric antigen receptor T cells targeting CD38 and SLAMF7 with independent signalling demonstrate preclinical efficacy and safety in Multiple Myeloma. Cancer immunology research (2024)
Audrey Abecassis, Nathalie Roders, Maxime Fayon, Caroline Choisy, Elisabeth Nelson, Stephanie Harel, Bruno Royer, Camille Villesuzanne, Alexis Talbot, David Garrick, Michele Goodhardt, Jean-Christophe Bories, Mike Burbridge, Bertrand Arnulf, Jean-Christophe Bories
CAR-T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment. EJHaem 3 (3) (2022)
Darya Deen, Falk Butter, Deborah E Daniels, Ivan Ferrer-Vicens, Daniel C J Ferguson, Michelle L Holland, Vasiliki Samara, Jacqueline A Sloane-Stanley, Helena Ayyub, Matthias Mann, Jan Frayne, David Garrick, Douglas Vernimmen
Identification of the transcription factor MAZ as a regulator of erythropoiesis. Blood advances 5 (15) (2021)
Antoine David, Simone Zocchi, Alexis Talbot, Caroline Choisy, Ashley Ohnona, Julien Lion, Wendy Cuccuini, Jean Soulier, Bertrand Arnulf, Jean-Christophe Bories, Michele Goodhardt, David Garrick
The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signalling. Leukemia 35 (6) (2020)

David Garrick.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David Garrick